Comment on: Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia

Am J Ophthalmol. 2020 May:213:322-323. doi: 10.1016/j.ajo.2019.10.039. Epub 2020 Mar 3.

Authors

Travers Weaver¹, William H Ross¹

Affiliation

¹ Vancouver, British Columbia, Canada.

PMID: 32139080
DOI: 10.1016/j.ajo.2019.10.039

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost-Benefit Analysis
Eye Diseases*
Humans
Vision, Ocular
Vitrectomy*
Vitreous Body